A carregar...

Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study

BACKGROUND: Dry eye disease (DED) affects more than 14% of the elderly population causing decrease of quality of life, high costs and vision impairment. Current treatments for DED aim at lubricating and controlling inflammation of the ocular surface. Development of novel therapies targeting differen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Ophthalmol
Main Authors: Sacchetti, Marta, Lambiase, Alessandro, Schmidl, Doreen, Schmetterer, Leopold, Ferrari, Mauro, Mantelli, Flavio, Allegretti, Marcello, Garhoefer, Gerhard
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6922013/
https://ncbi.nlm.nih.gov/pubmed/30944103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2018-312470
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!